Thus, CARD8-AS1 may inhibit tumor progression in lung adenocarcinoma by targeting the miR-650/Bax axis, which underlies its value and utility as a prognostic marker for lung adenocarcinoma patients. Here, CARD8 is linked to neoplasm.